PriveBio

PriveBio develops precision therapeutics targeting metabolic dysfunction and fibro-inflammation in cardiorenal diseases, including obesity and chronic kidney disease, by utilizing human proteo-genomics data from extensive datasets. The company focuses on validated therapeutic targets to improve patient outcomes in these complex conditions.

Traction 1/10

Cambridge, United Kingdom · HQ

Founded 2023250+ followers

Biotechnology

Updated 7 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

1 founder

Olga Granaturova

Founder/Board Director

Product

Features

PriveBio develops precision therapeutics targeting metabolic dysfunction and fibro-inflammation in cardiorenal diseases, including obesity and chronic kidney disease, by utilizing human proteo-genomics data from extensive datasets. The company focuses on validated therapeutic targets to improve patient outcomes in these complex conditions.